Edinburgh, United Kingdom
Bioliberty
€3.0M
Series A
Summary
Bioliberty raised a €2.95 million Series A extension to expand its rehabilitation technology and AI capabilities. Bioliberty is a developer of soft-robotic rehabilitation technology.